BioDelivery Sciences.

Position+TRIANGLE BRIEFS: RALEIGH

Drugmaker BioDelivery Sciences sold $50 million in preferred stock to a group led by New York-based Broadfin Capital and named Herm Cukier chief executive officer. Cukier was a senior vice president of Allergan. He...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT